Kosten T R, Morgan C, Kosten T A
Department of Psychiatry, Yale University School of Medicine, New Haven, CT.
J Subst Abuse Treat. 1990;7(1):51-4. doi: 10.1016/0740-5472(90)90035-o.
Among 40 opioid addicts treated as outpatients with sublingual buprenorphine (2-8 mg daily) for a month, depressive symptoms significantly decreased in the 19 who were depressed at intake to treatment.